Topic

New Jersey

A collection of 536 issues

Work With Your Doctor to Get Naglazyme (galsulfase) Approved by Aetna (CVS Health) in New Jersey

Answer Box: Getting Naglazyme Covered by Aetna (CVS Health) in New Jersey Eligibility: Patients with confirmed MPS VI diagnosis via enzyme assay or genetic testing can get Naglazyme (galsulfase) covered through Aetna's prior authorization process. Fastest path: Work with your metabolic specialist to submit the Naglazyme Precertification Form

How to Get Nourianz (Istradefylline) Covered by Blue Cross Blue Shield in New Jersey: Complete Guide with Forms, Appeals, and Scripts

Answer Box: Getting Nourianz Covered by Blue Cross Blue Shield in New Jersey Nourianz (istradefylline) requires prior authorization from Blue Cross Blue Shield with step therapy requirements. Most BCBS plans require you to try and fail at least two generic alternatives (like entacapone or pramipexole) before approving Nourianz. Your fastest

Getting Oxbryta (Voxelotor) Covered by Cigna in New Jersey After FDA Withdrawal: Appeals Guide and Alternatives

Answer Box: Key Facts for New Jersey Patients Oxbryta (voxelotor) was withdrawn from the U.S. market in September 2024 due to safety concerns. Cigna now denies all new prior authorization requests. For New Jersey residents, your fastest path forward is: (1) Work with your hematologist to transition to FDA-approved

Getting Nucala (Mepolizumab) Approved by Humana in New Jersey: Complete Timeline and Appeals Guide

Answer Box: Fast Track to Nucala Coverage For Humana members in New Jersey: Nucala (mepolizumab) requires prior authorization with 7-day standard review (14 days through 2024). Submit complete clinical documentation including eosinophil counts, failed step therapy trials, and asthma control measures through Humana's provider portal. If denied, you

How to Get Ofev (nintedanib) Covered by UnitedHealthcare in New Jersey: Appeals Guide 2025

Answer Box: Getting Ofev Covered by UnitedHealthcare in New Jersey Ofev (nintedanib) requires prior authorization from UnitedHealthcare in New Jersey and may be subject to step therapy requirements. Your fastest path to approval: (1) Have your pulmonologist submit a prior authorization request through the OptumRx provider portal with complete clinical

How to Get Gilenya (Fingolimod) Covered by Aetna CVS Health in New Jersey: Prior Authorization Guide & Appeal Strategies

Answer Box: Getting Gilenya Covered by Aetna CVS Health in New Jersey Aetna CVS Health requires prior authorization for Gilenya (fingolimod) in New Jersey, with mandatory step therapy requiring generic fingolimod first. The fastest path: 1) Have your neurologist document why generic fingolimod failed or is contraindicated, 2) Submit complete

How to Get Oxervate (Cenegermin) Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization & Appeal Guide

Answer Box: Getting Oxervate Covered by UnitedHealthcare in New Jersey Oxervate requires prior authorization from UnitedHealthcare with strict medical necessity criteria. You'll need confirmed Stage 2 or 3 neurotrophic keratitis, documented failure of at least one over-the-counter artificial tear, and prescribing by an ophthalmologist. Submit through the UnitedHealthcare

Getting Cometriq (Cabozantinib) Covered by UnitedHealthcare in New Jersey: Prior Authorization, Appeals, and Step Therapy Protections

Answer Box: Getting Cometriq (Cabozantinib) Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Cometriq (cabozantinib) capsules for metastatic medullary thyroid carcinoma (MTC) but does not require step therapy for this specific indication. Your fastest path: 1) Confirm MTC diagnosis with your oncologist, 2) Submit PA through UnitedHealthcare

How to Get Retevmo (selpercatinib) Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo Covered by UnitedHealthcare in New Jersey Retevmo (selpercatinib) requires prior authorization from UnitedHealthcare OptumRx. Key requirements include FDA-approved RET fusion testing, specific cancer diagnosis documentation, and possible step therapy compliance. If denied, New Jersey's Independent Health Care Appeals Program (IHCAP) provides external review after

How to Get Ofev (nintedanib) Covered by Aetna (CVS Health) in New Jersey: Complete Appeals Guide with Templates

Answer Box: Getting Ofev (nintedanib) Covered by Aetna (CVS Health) in New Jersey If Aetna (CVS Health) denied your Ofev (nintedanib) prescription for IPF, SSc-ILD, or progressive fibrosing ILD in New Jersey, you have strong appeal rights. First step: Gather your HRCT report, pulmonary function tests, and specialist consultation notes.